The Division of Hematology/Oncology offers expertise in the diagnosis and treatment of a broad spectrum of blood disorders and malignant diseases. The Hemology/Oncology faculty participate in specialized patient care and research programs in the areas of solid tumors, hematologic malignancies, thrombosis, bleeding disorders, sickle cell anemia, and bone marrow transplantation. In association with other members of the UNC Lineberger Comprehensive Cancer Center, specialized interdisciplinary oncology clinics and conferences are held weekly in the areas of breast cancer, thoracic, gastrointestinal, genitourinary, sarcoma, neuro-oncology, melanoma, and head and neck malignancies. Centers which are central to implementing the patient care and research missions of the Division include the Lineberger Comprehensive Cancer Center, one of the foremost cancer research centers in the country, and the nationally recognized Hemostasis and Thrombosis, Hemophilia, and Sickle Cell Centers.
Hematology & Oncology News
-
“Know Your Girls” campaign draws attention to racial differences related to breast cancer
A new campaign aims to reduce the black women mortality rate from breast cancer by 25 percent over five years, in 10 US communities. Katherine Reeder-Hayes, MD, in the division of hematology and oncology was interviewed for this WRAL news story, recognizing black women are 40 percent more likely to die from breast cancer than white women.
-
Patients with blood disorders don’t receive recommended vaccines and screenings
(Republished from the UNC Health Care and UNC School of Medicine Newsroom) New research from the University of North Carolina School of Medicine has found that only a low percentage of hospital patients being treated for immune-mediated blood disorders, such as immune thrombocytopenic purpura, receive the recommended vaccinations and infectious disease screenings. “The management of patients with … Continued
-
Medicine introduces new multi-disciplinary blood research center
The UNC Department of Medicine announces the formation of the new UNC Blood Research Center (UNC BRC), administratively housed within the division of hematology and oncology. With faculty participation from medicine, pediatrics, pathology and biochemistry, the Center will promote basic and clinical research in non-malignant blood disorders, building on ground-breaking discoveries that laid the foundation … Continued